FDA Approves Enspryng (Satralizumab) for Thyroid Eye Disease
FDA Approves Enspryng (Satralizumab) for Thyroid Eye Disease Pharmaceutical Executive
Regulatory Approvals
FDA Approves New Nonprescription Treatment for Eye Redness
FDA Approves New Nonprescription Treatment for Eye Redness Medscape
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia Ophthalmology Times
FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis
FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis NeurologyLive
Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia PR Newswire